Commission Actions

FTC Issues Supplemental Proposed Amendments to its Amplifier Rule to Make Testing Methods More Useful to Consumers

Date

July 25, 2023

The Federal Trade Commission has issued supplemental proposed amendments to its Amplifier Rule to help consumers make direct comparisons of home entertainment amplifiers. The Amplifier Rule, formally...

Federal Register Notice

Trade Regulation Rule Relating to Power Output Claims for Amplifiers Utilized in Home Entertainment Products; Supplemental Notice of Proposed Rulemaking

Date

July 25, 2023

Case Timeline Item

Intercontinental Exchange, Inc./Black Knight, Inc., In the Matter of (timeline item) - July 25, 2023

Date

July 25, 2023

Order Withdrawing This Matter from Adjudication (107.71 KB)

Case Timeline Item

Resident Home LLC, In the Matter of (timeline item) - July 25, 2023

Date

July 25, 2023

Case Timeline Item

Amgen, Inc. and Horizon Therapeutics plc, In the Matter of (timeline item) - July 25, 2023

Date

July 25, 2023

Notice of Appearance of Counsel for Complaint - S. Mohr (915.41 KB)

Case Timeline Item

IQVIA Holdings/Propel Media, In the Matter of (timeline item) - July 25, 2023

Date

July 25, 2023

Notice of Appearance Filed by Counsel Supporting the Complaint-Cory Gordon (1.59 MB)

July 24, 2023

Case Timeline Item

IQVIA Holdings/Propel Media, In the Matter of (timeline item) - July 24, 2023

Date

July 24, 2023

Notice of Appearance of Counsel for Complaint - J. Moy (1.41 MB)

Notice of Appearance of Counsel for Complaint - J. Fleury (1.41 MB)

Notice of Appearance of Counsel for Complaint - S. Mohr (1.41 MB)

Notice of Appearance of Counsel for Complaint - M. Seo (1.41 MB)

Notice of Appearance of Counsel for Respondent - C. Fiebig (1.35 MB)

Notice of Appearance of Counsel for Complaint - J. Andrew (1.49 MB)

Notice of Appearance of Counsel for Respondent - S. Sternlieb (1.16 MB)

Notice of Appearance of Counsel for Complaint - S. Bovee (1.54 MB)

Notice of Appearance of Counsel for Respondent - L. M. Madalone (1.03 MB)

Notice of Appearance of Counsel for Respondent - R. Taylor (1.03 MB)

Notice of Appearance of Counsel for Complaint - L. Verbeck (1.52 MB)

Notice of Appearance of Counsel for Respondent - M. Moiseyev (1.06 MB)

Notice of Appearance of Counsel for Respondent - A. Tulumello (1.13 MB)

Notice of Appearance of Counsel for Respondent - E. Ryan (1.16 MB)

Notice of Appearance of Counsel for Respondent - M. Perry (1.03 MB)

Notice of Appearance of Counsel for Respondent - J. Wesneski (1.02 MB)

July 21, 2023

Case Timeline Item

Amgen, Inc. and Horizon Therapeutics plc, In the Matter of (timeline item) - July 21, 2023

Date

July 21, 2023

Joint Motion to Continue Administrative Hearing (1.33 MB)

Notice of Appearance of Counsel for Complaint - R. Sanborn (1.03 MB)

July 20, 2023

Statement of Chair Lina M. Khan Regarding the Policy Statement Concerning Reliance on Prior PBM-Related Advocacy Statements and Reports (145.49 KB)

Statement of Chair Lina M. Khan Regarding the Policy Statement Concerning Reliance on Prior PBM-Related Advocacy Statements and Reports

Date

July 20, 2023

Lina M. Khan, Chair

Statement of Commissioner Rebecca Kelly Slaughter Regarding the Health Breach Notification Rule and the Biometric Policy Statement as Prepared for Delivery (151.49 KB)

Statement of Commissioner Rebecca Kelly Slaughter Regarding the Health Breach Notification Rule and the Biometric Policy Statement as Prepared for Delivery

Date

July 20, 2023

Rebecca Kelly Slaughter, Commissioner

FTC Votes to Issue Statement Withdrawing Prior Pharmacy Benefit Manager Advocacy

Date

July 20, 2023

The Federal Trade Commission voted to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit mangers (PBMs) that no longer reflect current...

FTC and HHS Warn Hospital Systems and Telehealth Providers about Privacy and Security Risks from Online Tracking Technologies

Date

July 20, 2023

The Federal Trade Commission and the U.S. Department of Health and Human Services' Office for Civil Rights (OCR) are cautioning hospitals and telehealth providers about the privacy and security risks...

Federal Register Notice

Children’s Online Privacy Protection Rule Proposed Parental Consent Method; Application of the ESRB Group for Approval of Parental Consent Method

Date

July 20, 2023

Case Timeline Item

Microsoft/Activision Blizzard, In the Matter of (timeline item) - July 20, 2023

Date

July 20, 2023

Order Withdrawing Matter from Adjudication (115.08 KB)

July 19, 2023

Statement of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines (188.28 KB)

Statement Of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines

Date

July 19, 2023

Rebecca Kelly Slaughter, Commissioner

Matter Number

P234000

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines (196.08 KB)

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines

Date

July 19, 2023

Lina M. Khan, Chair

Matter Number

P234000

Statement of Commissioner Alvaro M. Bedoya Joined by Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter Regarding FTC-DOJ Proposed Merger Guidelines (299.73 KB)

Statement of Commissioner Alvaro M. Bedoya Joined by Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter Regarding the Proposed Merger Guidelines Issued by the Federal Trade Commission & U.S. Department of Justice

Date

July 19, 2023

Alvaro Bedoya, Commissioner

Matter Number

P234000

Policy Statements

FTC-DOJ Merger Guidelines (Draft for Public Comment)

Date

July 19, 2023

Matter Number

P859910

Draft FTC-DOJ Merger Guidelines for Public Comment (867.38 KB)

FTC Takes Action Against Makers of Sobrenix Supplement That Deceptively Claimed to Reduce Alcohol Cravings, Relied on Fake Endorsements

Date

July 19, 2023

The Federal Trade Commission is taking action under the FTC Act and the Opioid Addiction Recovery Fraud Prevention Act of 2018 (OARFPA) against the makers of Sobrenix, which was marketed to reduce and...